Medifast Inc
corporate_fare Company Profile
Medifast Inc (NYSE:MED) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 20 items for MED at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-28, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for MED spans 4, SCHEDULE 13D/A, 10-Q, 8-K.
Recent high-impact activity:
- Director Kiai Parsa Adds $529K More in Medifast Stock, Extending Accumulation Streak
- Steamboat Capital Partners Reveals 7.1% Medifast Stake After $8.4M Buying Spree
- Director Kiai Parsa Buys $842,699 of Medifast Stock
- Medifast Q2 Revenue Drops 28%, Loss Widens as Coach Exodus Continues
- Medifast Q2 Revenue Drops 28%, Loss Deepens; Full-Year Loss Guidance Issued
Financial Snapshot
Short Interest & Short Volume
20.02 days to coverFINRA reported short interest of 1,862,070 shares in MED as of the September 15, 2026 settlement, a 1.1% decrease from the prior period — about 20.0 days to cover at its recent average daily volume. On October 2, 2026, 64.7% of MED volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.